Lupus Science and Medicine (Dec 2022)
1207 Update on Progress of the Mesenchymal Stromal Cell Trial in Refractory Lupus
- R Martin,
- S Sheikh,
- G Gilkeson,
- R Ramsey-Goldman,
- M Ishimori,
- K Kalunian,
- U Shah,
- E Goldmuntz,
- M MacKay,
- D Kamen,
- B Welch,
- C Arriens,
- SS Lim,
- A Khosroshahi,
- P Nietert,
- L Sirline
Affiliations
- R Martin
- 1Paediatric Endocrinology and Diabetes, Tallaght University Hospital, Dublin, Ireland
- S Sheikh
- 6University of North Carolina Chapel Hill, Chapel Hill, NC
- G Gilkeson
- Medical University of South Carolina, Charleston, South Carolina, USA
- R Ramsey-Goldman
- Northwestern University/The Feinberg School of Medicine, Chicago IL 60611, USA
- M Ishimori
- 4Cedars Sinai Medical Centre, Rheumatology, Los Angeles, USA
- K Kalunian
- UCSD School of Medicine, La Jolla, California, USA
- U Shah
- Alder Hey Children`s NHS Foundation Trust
- E Goldmuntz
- Division of Cardiology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- M MacKay
- Plan-it-Safe, Children’s Hospital of Eastern Ontario, Canada
- D Kamen
- Medical University of South Carolina, Charleston, South Carolina, USA
- B Welch
- Department of Radiology, Neuroradiology Division,University of Texas Southwestern Medical Center, Dallas, Texas, USA
- C Arriens
- 3Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology, Oklahoma City, USA
- SS Lim
- 2Emory Medical Center, Atlanta, GA
- A Khosroshahi
- 2Emory Medical Center, Atlanta, GA
- P Nietert
- 1Medical University of South Carolina, Charleston, SC
- L Sirline
- 1Medical University of South Carolina, Charleston, SC
- DOI
- https://doi.org/10.1136/lupus-2022-lupus21century.89
- Journal volume & issue
-
Vol. 9,
no. Suppl 3
Abstract
No abstracts available.
